3-Bromo-4-Methyl-2-Pyridinamine Bulk Price 2026: Technical & Commercial Outlook
- Global bulk pricing for 3-Bromo-4-methyl-2-pyridinamine in 2026 is shaped by raw material volatility, synthesis complexity, and demand from pharmaceutical intermediates markets.
- Industrial purity (≥98%) and consistent COA documentation are critical for cost efficiency in multi-step API syntheses.
- NINGBO INNO PHARMCHEM CO.,LTD. offers scalable supply with competitive 2026 bulk pricing based on verified manufacturing process control and route optimization.
As the pharmaceutical and agrochemical sectors intensify R&D into novel heterocyclic scaffolds, demand for specialized building blocks like 3-Bromo-4-methyl-2-pyridinamine (also known as 2-Amino-3-bromo-4-picoline or 3-Bromo-4-methylpyridin-2-amine) continues to rise. With CAS number 40073-38-9, this brominated pyridine derivative serves as a pivotal intermediate in Suzuki couplings, Buchwald-Hartwig aminations, and other cross-coupling reactions. For procurement teams evaluating 2026 budgets, understanding the technical drivers behind bulk pricing is essential to secure reliable, cost-effective supply.
Global Bulk Pricing Trends for 3-Bromo-4-Methyl-2-Pyridinamine in 2026
Early 2026 market indicators suggest moderate price stabilization for high-purity 3-Bromo-4-methyl-2-pyridinamine, following post-pandemic supply chain recalibration and improved bromine sourcing logistics. However, pricing remains sensitive to several structural factors:
- Synthesis route complexity: Multi-step routes involving bromination of protected 4-methyl-2-aminopyridine precursors typically yield higher impurity profiles unless rigorously controlled, increasing purification costs.
- Regulatory compliance: REACH, TSCA, and ICH Q3 guidelines necessitate stringent impurity profiling, directly affecting COA robustness and batch-to-batch consistency.
- Geopolitical raw material access: Bromine and specialty solvents face regional export restrictions, influencing landed costs in North America and Europe.
When sourcing high-purity 3-Bromo-4-methyl-2-pyridinamine, buyers should prioritize suppliers with vertically integrated manufacturing capabilities to mitigate these variables.
Factors Influencing Wholesale Costs: Purity, Volume, and Logistics
Bulk pricing for 3-Bromo-4-methyl-2-pyridinamine is not linear—it scales non-uniformly with order volume due to fixed costs in reaction setup, workup, and analytical validation. The table below outlines indicative 2026 FOB China pricing tiers from a top-tier global manufacturer, reflecting standard industrial purity (≥98% by HPLC) and full COA documentation:
| Order Volume (kg) | Industrial Purity (≥98%) | Estimated Bulk Price Range (USD/kg) | Lead Time |
|---|---|---|---|
| 1 – 10 | Yes | $420 – $480 | 2–3 weeks |
| 10 – 50 | Yes | $360 – $410 | 3–4 weeks |
| 50 – 200 | Yes | $310 – $350 | 4–6 weeks |
| 200+ | Yes (custom QC) | Negotiable (volume-based) | 6–8 weeks |
Note: Prices assume standard packaging (25 kg fiber drums, double-lined), standard COA (HPLC, NMR, MS, residual solvents), and exclude customs/duties. Custom synthesis routes or ≥99% purity may incur premiums of 15–25%.
How to Request Custom Quotes from Verified Manufacturers
For B2B buyers seeking long-term partnerships, engaging directly with manufacturers who control the entire manufacturing processNINGBO INNO PHARMCHEM CO.,LTD., a premier global manufacturer based in China, specializes in halogenated pyridine derivatives with GMP-aligned quality systems and scalable reactor capacity (up to 2000 L).
The company’s optimized synthesis route3-Bromo-4-methyl-2-pyridinamine minimizes genotoxic impurities and ensures reproducible yields (>85% isolated yield), translating to stable bulk economics. Their technical team provides full regulatory support, including DMFs, spectral data, and custom COA templates aligned with client specifications.
To obtain a precise 2026 quote, procurement managers should specify:
- Required annual volume and delivery schedule
- Purity threshold (e.g., 98% vs. 99%)
- Analytical method preferences (HPLC vs. GC)
- Intended application (e.g., oncology API intermediate)
NINGBO INNO PHARMCHEM CO.,LTD. offers rapid quote turnaround (<48 hours) and supports third-party audits, ensuring transparency in both industrial purity
In summary, while macroeconomic pressures persist, strategic partnerships with technically capable manufacturers enable buyers to lock in favorable 2026 bulk pricing for 3-Bromo-4-methyl-2-pyridinamine without compromising on quality or compliance.